Covid vaccine: Single-dose Johnson & Johnson jab is 66% effective
Janssen, a pharmaceutical firm owned by Johnson & Johnson, aims to make one billion doses this year. …
Crucially, the Janssen trial looked at giving just one dose of the vaccine, which makes it significantly easier to roll out than those requiring two. It is also investigating whether giving two doses will give either stronger or longer-lasting protection.
About The Author
